Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthetic Molecules Private Limited is an Indian pharmaceutical company established in 2003, specializing in the development, manufacture, and supply of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Headquartered in Mumbai with manufacturing and R&D facilities in Indore, the company serves a global clientele across therapeutic areas including cardiovascular health, diabetes, dermatology, and musculoskeletal disorders. Synthetic Molecules is ISO 9001:2015 certified and operates as a Contract Development and Manufacturing Organization (CDMO), providing custom synthesis and process optimization services. Its product portfolio features a diverse range of small molecules and vitamin D analogs, such as Alfacalcidol and Calcipotriol, as well as essential medicines like Dopamine HCl and Glipizide. The company is recognized for its commitment to quality and cost-effective pharmaceutical solutions, supporting both established pharmaceutical firms and emerging biotech startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthetic Molecules.